 |
PDBsum entry 1far
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Serine/threonine protein kinase
|
PDB id
|
|
|
|
1far
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Proc Natl Acad Sci U S A
93:8312-8317
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
|
|
H.R.Mott,
J.W.Carpenter,
S.Zhong,
S.Ghosh,
R.M.Bell,
S.L.Campbell.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Raf-1 protein kinase is the best-characterized downstream effector of
activated Ras. Interaction with Ras leads to Raf-1 activation and results in
transduction of cell growth and differentiation signals. The details of Raf-1
activation are unclear, but our characterization of a second Ras-binding site in
the cysteine-rich domain (CRD) and the involvement of both Ras-binding sites in
effective Raf-1-mediated transformation provides insight into the molecular
aspects and consequences of Ras-Raf interactions. The Raf-1 CRD is a member of
an emerging family of domains, many of which are found within signal transducing
proteins. Several contain binding sites for diacylglycerol (or phorbol esters)
and phosphatidylserine and are believed to play a role in membrane translocation
and enzyme activation. The CRD from Raf-1 does not bind diacylglycerol but
interacts with Ras and phosphatidylserine. To investigate the ligand-binding
specificities associated with CRDs, we have determined the solution structure of
the Raf-1 CRD using heteronuclear multidimensional NMR. We show that there are
differences between this structure and the structures of two related domains
from protein kinase C (PKC). The differences are confined to regions of the CRDs
involved in binding phorbol ester in the PKC domains. Since phosphatidylserine
is a common ligand, we expect its binding site to be located in regions where
the structures of the Raf-1 and PKC domains are similar. The structure of the
Raf-1 CRD represents an example of this family of domains that does not bind
diacylglycerol and provides a framework for investigating its interactions with
other molecules.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.D.Stewart,
B.Morgan,
F.Massi,
and
T.I.Igumenova
(2011).
Probing the determinants of diacylglycerol binding affinity in the C1B domain of protein kinase Cα.
|
| |
J Mol Biol,
408,
949-970.
|
 |
|
|
|
|
 |
M.D.Smith,
C.G.Sudhahar,
D.Gong,
R.V.Stahelin,
and
M.D.Best
(2009).
Modular synthesis of biologically active phosphatidic acid probes using click chemistry.
|
| |
Mol Biosyst,
5,
962-972.
|
 |
|
|
|
|
 |
T.Niault,
I.Sobczak,
K.Meissl,
G.Weitsman,
D.Piazzolla,
G.Maurer,
F.Kern,
K.Ehrenreiter,
M.Hamerl,
I.Moarefi,
T.Leung,
O.Carugo,
T.Ng,
and
M.Baccarini
(2009).
From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity.
|
| |
J Cell Biol,
187,
335-342.
|
 |
|
|
|
|
 |
J.E.Chrencik,
A.Brooun,
H.Zhang,
I.I.Mathews,
G.L.Hura,
S.A.Foster,
J.J.Perry,
M.Streiff,
P.Ramage,
H.Widmer,
G.M.Bokoch,
J.A.Tainer,
G.Weckbecker,
and
P.Kuhn
(2008).
Structural basis of guanine nucleotide exchange mediated by the T-cell essential Vav1.
|
| |
J Mol Biol,
380,
828-843.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Rapley,
V.L.Tybulewicz,
and
K.Rittinger
(2008).
Crucial structural role for the PH and C1 domains of the Vav1 exchange factor.
|
| |
EMBO Rep,
9,
655-661.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Clapéron,
and
M.Therrien
(2007).
KSR and CNK: two scaffolds regulating RAS-mediated RAF activation.
|
| |
Oncogene,
26,
3143-3158.
|
 |
|
|
|
|
 |
D.T.Leicht,
V.Balan,
A.Kaplun,
V.Singh-Gupta,
L.Kaplun,
M.Dobson,
and
G.Tzivion
(2007).
Raf kinases: function, regulation and role in human cancer.
|
| |
Biochim Biophys Acta,
1773,
1196-1212.
|
 |
|
|
|
|
 |
H.Al-Ali,
T.J.Ragan,
X.Gao,
and
T.K.Harris
(2007).
Reconstitution of modular PDK1 functions on trans-splicing of the regulatory PH and catalytic kinase domains.
|
| |
Bioconjug Chem,
18,
1294-1302.
|
 |
|
|
|
|
 |
V.Khazak,
I.Astsaturov,
I.G.Serebriiskii,
and
E.A.Golemis
(2007).
Selective Raf inhibition in cancer therapy.
|
| |
Expert Opin Ther Targets,
11,
1587-1609.
|
 |
|
|
|
|
 |
E.Harjes,
S.Harjes,
S.Wohlgemuth,
K.H.Müller,
E.Krieger,
C.Herrmann,
and
P.Bayer
(2006).
GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1.
|
| |
Structure,
14,
881-888.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Terai,
and
M.Matsuda
(2006).
The amino-terminal B-Raf-specific region mediates calcium-dependent homo- and hetero-dimerization of Raf.
|
| |
EMBO J,
25,
3556-3564.
|
 |
|
|
|
|
 |
I.Korichneva
(2005).
Redox regulation of cardiac protein kinase C.
|
| |
Exp Clin Cardiol,
10,
256-261.
|
 |
|
|
|
|
 |
B.R.Lentz
(2003).
Exposure of platelet membrane phosphatidylserine regulates blood coagulation.
|
| |
Prog Lipid Res,
42,
423-438.
|
 |
|
|
|
|
 |
E.Y.Chan,
S.L.Stang,
D.A.Bottorff,
and
J.C.Stone
(2002).
Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity.
|
| |
Mol Carcinog,
33,
189-197.
|
 |
|
|
|
|
 |
M.A.Booden,
S.L.Campbell,
and
C.J.Der
(2002).
Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation.
|
| |
Mol Cell Biol,
22,
2487-2497.
|
 |
|
|
|
|
 |
M.Rizzo,
and
G.Romero
(2002).
Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade.
|
| |
Pharmacol Ther,
94,
35-50.
|
 |
|
|
|
|
 |
T.Bondeva,
A.Balla,
P.Várnai,
and
T.Balla
(2002).
Structural determinants of Ras-Raf interaction analyzed in live cells.
|
| |
Mol Biol Cell,
13,
2323-2333.
|
 |
|
|
|
|
 |
A.Chiloeches,
C.S.Mason,
and
R.Marais
(2001).
S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.
|
| |
Mol Cell Biol,
21,
2423-2434.
|
 |
|
|
|
|
 |
E.Kerkhoff,
and
U.R.Rapp
(2001).
The Ras-Raf relationship: an unfinished puzzle.
|
| |
Adv Enzyme Regul,
41,
261-267.
|
 |
|
|
|
|
 |
N.V.Grishin
(2001).
Treble clef finger--a functionally diverse zinc-binding structural motif.
|
| |
Nucleic Acids Res,
29,
1703-1714.
|
 |
|
|
|
|
 |
A.Yuryev,
M.Ono,
S.A.Goff,
F.Macaluso,
and
L.P.Wennogle
(2000).
Isoform-specific localization of A-RAF in mitochondria.
|
| |
Mol Cell Biol,
20,
4870-4878.
|
 |
|
|
|
|
 |
B.H.Zhang,
and
K.L.Guan
(2000).
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.
|
| |
EMBO J,
19,
5429-5439.
|
 |
|
|
|
|
 |
B.Hoyos,
A.Imam,
R.Chua,
C.Swenson,
G.X.Tong,
E.Levi,
N.Noy,
and
U.Hämmerling
(2000).
The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors.
|
| |
J Exp Med,
192,
835-845.
|
 |
|
|
|
|
 |
C.R.Weinstein-Oppenheimer,
W.L.Blalock,
L.S.Steelman,
F.Chang,
and
J.A.McCubrey
(2000).
The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors.
|
| |
Pharmacol Ther,
88,
229-279.
|
 |
|
|
|
|
 |
J.H.Hurley,
and
S.Misra
(2000).
Signaling and subcellular targeting by membrane-binding domains.
|
| |
Annu Rev Biophys Biomol Struct,
29,
49-79.
|
 |
|
|
|
|
 |
C.Ostermeier,
and
A.T.Brunger
(1999).
Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A.
|
| |
Cell,
96,
363-374.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.S.Mason,
C.J.Springer,
R.G.Cooper,
G.Superti-Furga,
C.J.Marshall,
and
R.Marais
(1999).
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.
|
| |
EMBO J,
18,
2137-2148.
|
 |
|
|
|
|
 |
D.J.Bartels,
D.A.Mitchell,
X.Dong,
and
R.J.Deschenes
(1999).
Erf2, a novel gene product that affects the localization and palmitoylation of Ras2 in Saccharomyces cerevisiae.
|
| |
Mol Cell Biol,
19,
6775-6787.
|
 |
|
|
|
|
 |
T.Okada,
C.D.Hu,
T.G.Jin,
K.Kariya,
Y.Yamawaki-Kataoka,
and
T.Kataoka
(1999).
The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.
|
| |
Mol Cell Biol,
19,
6057-6064.
|
 |
|
|
|
|
 |
G.Müller,
P.Storz,
S.Bourteele,
H.Döppler,
K.Pfizenmaier,
H.Mischak,
A.Philipp,
C.Kaiser,
and
W.Kolch
(1998).
Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling.
|
| |
EMBO J,
17,
732-742.
|
 |
|
|
|
|
 |
M.Daub,
J.Jöckel,
T.Quack,
C.K.Weber,
F.Schmitz,
U.R.Rapp,
A.Wittinghofer,
and
C.Block
(1998).
The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation.
|
| |
Mol Cell Biol,
18,
6698-6710.
|
 |
|
|
|
|
 |
R.E.Cutler,
R.M.Stephens,
M.R.Saracino,
and
D.K.Morrison
(1998).
Autoregulation of the Raf-1 serine/threonine kinase.
|
| |
Proc Natl Acad Sci U S A,
95,
9214-9219.
|
 |
|
|
|
|
 |
A.C.Newton
(1997).
Regulation of protein kinase C.
|
| |
Curr Opin Cell Biol,
9,
161-167.
|
 |
|
|
|
|
 |
D.K.Morrison,
and
R.E.Cutler
(1997).
The complexity of Raf-1 regulation.
|
| |
Curr Opin Cell Biol,
9,
174-179.
|
 |
|
|
|
|
 |
J.H.Hurley,
A.C.Newton,
P.J.Parker,
P.M.Blumberg,
and
Y.Nishizuka
(1997).
Taxonomy and function of C1 protein kinase C homology domains.
|
| |
Protein Sci,
6,
477-480.
|
 |
|
|
|
|
 |
J.H.Hurley,
and
J.A.Grobler
(1997).
Protein kinase C and phospholipase C: bilayer interactions and regulation.
|
| |
Curr Opin Struct Biol,
7,
557-565.
|
 |
|
|
|
|
 |
J.R.Daugherty,
C.I.Murphy,
L.A.Doros-Richert,
A.Barbosa,
L.O.Kashala,
W.R.Ballou,
N.J.Snellings,
C.F.Ockenhouse,
and
D.E.Lanar
(1997).
Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies.
|
| |
Infect Immun,
65,
3631-3637.
|
 |
|
|
|
|
 |
M.Geyer,
and
A.Wittinghofer
(1997).
GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins.
|
| |
Curr Opin Struct Biol,
7,
786-792.
|
 |
|
|
|
|
 |
N.R.Michaud,
M.Therrien,
A.Cacace,
L.C.Edsall,
S.Spiegel,
G.M.Rubin,
and
D.K.Morrison
(1997).
KSR stimulates Raf-1 activity in a kinase-independent manner.
|
| |
Proc Natl Acad Sci U S A,
94,
12792-12796.
|
 |
|
|
|
|
 |
R.E.Cutler,
and
D.K.Morrison
(1997).
Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila.
|
| |
EMBO J,
16,
1953-1960.
|
 |
|
|
|
|
 |
Y.Ito,
K.Yamasaki,
J.Iwahara,
T.Terada,
A.Kamiya,
M.Shirouzu,
Y.Muto,
G.Kawai,
S.Yokoyama,
E.D.Laue,
M.Wälchli,
T.Shibata,
S.Nishimura,
and
T.Miyazawa
(1997).
Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
|
| |
Biochemistry,
36,
9109-9119.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Luo,
B.Diaz,
M.S.Marshall,
and
J.Avruch
(1997).
An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ.
|
| |
Mol Cell Biol,
17,
46-53.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |